Literature DB >> 9155641

Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells.

A Andoh1, Y Fujiyama, K Sumiyoshi, H Sakumoto, H Okabe, T Bamba.   

Abstract

The increased expression of decay-accelerating factor (DAF) has been detected in intestinal epithelial cells at the inflamed mucosa. In this study, we examined the effects of tumour necrosis factor (TNF)-alpha on DAF expression in three intestinal epithelial cell lines. DAF mRNA expression was evaluated by Northern blot analysis, and DAF protein expression was analysed by biotin labelling and immunoprecipitation. TNF-alpha induced a marked increase in DAF mRNA and protein expression in HT-29, T84 and Caco-2 cells. In HT-29 cells, the effects of TNF-a on DAF mRNA accumulation were observed in a dose-dependent manner; DAF mRNA accumulation reached a maximum at 3-6 hr, and then gradually decreased. These effects of TNF-alpha required de novo protein synthesis. Messenger RNA stability studies suggested that TNF-alpha partially regulated DAF gene expression by a posttranscriptional mechanism. Moreover, the combination of TNF-alpha and interleukin (IL)-4 induced an additive increase in DAF mRNA accumulation in HT-29 and T84 cells. In human intestinal epithelial cells, TNF-alpha acts as a potent inducer of DAF mRNA expression, indicating an important role for TNF-alpha in the regulation of DAF expression at the inflamed mucosa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155641      PMCID: PMC1456598          DOI: 10.1111/j.1365-2567.1997.00358.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Complement regulatory molecules: application to therapy and transplantation.

Authors:  B P Morgan
Journal:  Immunol Today       Date:  1995-06

2.  Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.

Authors:  A Andoh; Y Fujiyama; T Bamba; S Hosoda
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

3.  Superinduction of cytokine gene transcription by ciprofloxacin.

Authors:  K Riesbeck; M Sigvardsson; T Leanderson; A Forsgren
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

4.  Wheat germ agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells.

Authors:  R W Bryant; C A Granzow; M I Siegel; R W Egan; M M Billah
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

5.  In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium.

Authors:  D L Kooyman; G W Byrne; S McClellan; D Nielsen; M Tone; H Waldmann; T M Coffman; K R McCurry; J L Platt; J S Logan
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

6.  Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.

Authors:  E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

7.  Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.

Authors:  C P Braegger; S Nicholls; S H Murch; S Stephens; T T MacDonald
Journal:  Lancet       Date:  1992-01-11       Impact factor: 79.321

8.  Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.

Authors:  T Uesu; M Mizuno; H Inoue; J Tomoda; T Tsuji
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

9.  Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer.

Authors:  H Inoue; M Mizuno; T Uesu; T Ueki; T Tsuji
Journal:  Acta Med Okayama       Date:  1994-10       Impact factor: 0.892

10.  Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.

Authors:  K Koretz; S Brüderlein; C Henne; P Möller
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more
  9 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Regulation of epithelial cell functions by the intestinal milieu.

Authors:  Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells.

Authors:  K Kitamura; A Andoh; T Inoue; Y Amakata; K Hodohara; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells.

Authors:  A Andoh; Y Fujiyama; K Hata; Y Araki; H Takaya; M Shimada; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 5.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 6.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.

Authors:  Manu Banadakoppa; Daniel Liebenthal; David E Nowak; Petri Urvil; Uma Yallampalli; Gerald M Wilson; Aparna Kishor; Chandra Yallampalli
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

8.  Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins.

Authors:  Fréderic Bétis; Patrick Brest; Véronique Hofman; Julie Guignot; Imad Kansau; Bernard Rossi; Alain Servin; Paul Hofman
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

9.  Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3.

Authors:  Marion Lenoir; Rebeca Martín; Edgar Torres-Maravilla; Sead Chadi; Pamela González-Dávila; Harry Sokol; Philippe Langella; Florian Chain; Luis G Bermúdez-Humarán
Journal:  Gut Microbes       Date:  2020-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.